Ae. Delosmonteros et al., SERUM-INSULIN IN CLOMIPHENE RESPONDERS AND NONRESPONDERS WITH POLYCYSTIC OVARIAN DISEASE, Revista de Investigacion Clinica, 47(5), 1995, pp. 347-353
Objective. To investigate insulin levels in women with polycystic ovar
ian disease (PCOD) who are responders or nonresponders to clomiphene c
itrate (CC). Design. Open and prospective study. Setting. Outpatient i
nfertility clinic of a third level medical institution. Patients. Ten
healthy women (group 1) and 35 PCOD women classified as responders (gr
oup 2 n = 10) or nonresponders (group 3 n = 25) on the basis of serum
progesterone greater than or equal to 19 nmol/L in response to CC repe
atedly administered in doses up to 250 mg/day for five days; they were
further subdivided if body mass index (BMI) was below (N) or above (H
) mean + 3 SD of group 1. Interventions. Blood samples were obtained i
n a 100-g, 2-hours oral glucose tolerance test (OGTT). Main outcome me
asures. Serum glucose, insulin, free testosterone (free-T), dehydroepi
androsterone sulphate (DHEA-S), and androstenedione (A) were determine
d in the samples OGTT and the areas under the curve (AUG) were calcula
ted. Results. Group 3 had higher BMI, basal LH, and insulin and AUC in
sulin than groups 1 and 2; free-T was higher in groups 2 and 3 than in
group;, and basal PRL was higher in group 2 compared to groups 1 and
3. When BMI less than or equal to 25.4 kg/m(2) (mean + 1 SD of group 1
) 77% of the PCOD cases responded (10 out of 13) whereas none with BMI
> 25.4 responded to CC (n = 22) irrespectively of basal insulin conce
ntration or AUC insulin. Conclusion. Moderate to excessive overweight
seems more frequently and closely associated to a negative CC response
in women with PCOD than hyperinsulinemia.